The Serpin-tine Search for Factors Associated with COVID-19 Severity in Patients with Chronic Obstructive Pulmonary Disease

Aaron Scott,Sinéad Weldon,Clifford C. Taggart

DOI: https://doi.org/10.1164/rccm.202205-0956ED

IF: 24.7

2022-09-17

American Journal of Respiratory and Critical Care Medicine

Abstract:The coronavirus disease (COVID-19) pandemic, which has been driven by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, has caused significant morbidity and mortality worldwide. With a range of clinical responses from asymptomatic to severe, it has particularly targeted the elderly and those suffering from underlying disease conditions. Individuals with chronic obstructive pulmonary disease (COPD) are susceptible to a range of respiratory viral infections, and it is therefore not surprising that COPD is a risk factor for hospitalization, mechanical ventilation, severe disease, and mortality in COVID-19 (1). The effects of the COVID-19 pandemic have been globally devastating; however, as new viral strains emerge and population immunity increases, focus has turned to those groups with greater risk of developing severe disease determined early in the pandemic with risk factors including age, sociodemographic status, and preexisting comorbid conditions (2). Preexisting chronic respiratory diseases, such as asthma, interstitial lung disease, and COPD, are associated with increased risk of poor outcome although the mechanisms remain poorly described (3). The use of primary bronchial epithelial cells (PBECs) from individuals with a range of lung conditions has proved useful in understanding altered responses in these cells at baseline and following infection to delineate disease mechanisms (4). New insights published in this Journal by Johansen and colleagues (pp. 712–729), provide experimental evidence supporting increased susceptibility and severity of infection in patients with COPD, using a well-defined air–liquid interface model of PBECs from patients with COPD and healthy volunteers (5). The use of such patient-derived cell models provides a much clearer path to translation than cell line or murine models of disease, although it will be interesting to see how these findings translate to viral infection of type-II pneumocytes (AT2), which are tied to the development of acute respiratory distress syndrome. This will, of course, be technically challenging, but the use of alveosphere culture models may help to address this to some extent (6).

respiratory system,critical care medicine